GSK un­veils long-term Shin­grix da­ta as shin­gles com­pe­ti­tion heats up

GSK’s mar­ket-lead­ing Shin­grix vac­cine proved ef­fec­tive against shin­gles more than 10 years post-ad­min­is­tra­tion, cre­at­ing a new hur­dle for a num­ber of po­ten­tial com­peti­tors.

Shin­grix was …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER